Sarah C Couch1, Jamie Crandell2, Irena King3, Abigail Peairs4, Amy S Shah5, Lawrence M Dolan6, Janet Tooze7, Tessa Crume8, Elizabeth Mayer-Davis9. 1. 3202 Eden Avenue, French Building East, Room 364, University of Cincinnati Medical Center, Cincinnati, OH 45267-0394. Electronic address: Sarah.Couch@uc.edu. 2. Carrington Hall #7460, School of Nursing and Department of Biostatistics, UNC, Chapel Hill, NC 27599. Electronic address: jbigelow@email.unc.edu. 3. MSC 10 5550, University of New Mexico, Albuquerque, NM 87131. Electronic address: iking@salud.unm.edu. 4. 3202 Eden Avenue, French Building East, Room 364, University of Cincinnati Medical Center, Cincinnati, OH 45267-0394. Electronic address: peairsal@ucmail.uc.edu. 5. 3333 Burnett Avenue, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229. Electronic address: amy.shah@cchmc.org. 6. 3333 Burnett Avenue, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229. Electronic address: larry.dolan@cchmc.org. 7. 1 Medical Center Blvd, Wake Forest School of Medicine, Winston-Salem, NC 27157. Electronic address: jtooze@wakehealth.edu. 8. 13001 E. 17th Place, University of Colorado, Aurora, CO 80045. Electronic address: Tessa.Crume@ucdenver.edu. 9. 1700 Martin Luther King Drive, Departments of Nutrition and Medicine, UNC, Chapel Hill, NC 27599. Electronic address: mayerdav@email.unc.edu.
Abstract
PURPOSE: In this longitudinal study we explored the relationships between plasma n-3 and n-6 polyunsaturated fatty acids (PUFAs) and Δ5 and Δ6 desaturase activities (D5D and D6D, respectively) and fasting lipids in youth with type 1 diabetes (T1D). METHODS: Incident cases of T1D in youth <20years of age who were seen for a baseline study visit (N=914) and a 1-year follow-up visit (N=416) were included. Fasting blood samples were obtained at each visit and plasma phospholipid n-6 PUFAs were measured, which included linoleic acid (LA), dihomo-γ-linolenic acid (DGLA) and arachidonic acid (AA); n-3 PUFAs included α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). Estimated D5D and D6D were calculated as FA product-to-precursor ratios, where D5D=AA/DGLA and D6D=DGLA/LA. To examine the longitudinal relationships between long chain PUFAs, desaturase activities and fasting plasma lipids in youth with T1D mixed effects models were used for each individual PUFAs, D5D and D6D, adjusted for demographics, clinic site, diabetes duration, insulin regimen, insulin dose/kg, HbA1c, insulin sensitivity score, and body mass index with random effects to account for the repeated measurements. FINDINGS: Favorable lipid associations were found between LA and low-density lipoprotein (LDL) cholesterol (β=-0.58, p<0.05); AA, plasma triglycerides (TG) (β=-0.04, p<0.05) and TG/high-density lipoprotein (HDL)-C ratio (β=-0.04, p<0.05); and D5D, plasma TG (β=-0.2, p<0.05) and TG/HDL-cholesterol ratio (β=-0.23, p<0.05). Findings were mixed for the n-3 PUFAs and DGLA: ALA was positively associated with plasma TG (β=0.33, p<0.05) and HDL cholesterol (β=9.86, p<0.05); EPA was positively associated with total cholesterol (β=8.17, p<0.05), LDL cholesterol (β=5.74, p<0.01) and HDL cholesterol (β=2.27, p<0.01); and DGLA was positively associated with TG/HDL-cholesterol ratio (β=0.05, P<0.05). CONCLUSION: Findings suggest that the most abundant PUFA, LA as well as its metabolic bi-product AA, may be important targets for CVD lipid risk factor reduction in youth with T1D.
PURPOSE: In this longitudinal study we explored the relationships between plasma n-3 and n-6 polyunsaturated fatty acids (PUFAs) and Δ5 and Δ6 desaturase activities (D5D and D6D, respectively) and fasting lipids in youth with type 1 diabetes (T1D). METHODS: Incident cases of T1D in youth <20years of age who were seen for a baseline study visit (N=914) and a 1-year follow-up visit (N=416) were included. Fasting blood samples were obtained at each visit and plasma phospholipid n-6 PUFAs were measured, which included linoleic acid (LA), dihomo-γ-linolenic acid (DGLA) and arachidonic acid (AA); n-3 PUFAs included α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). Estimated D5D and D6D were calculated as FA product-to-precursor ratios, where D5D=AA/DGLA and D6D=DGLA/LA. To examine the longitudinal relationships between long chain PUFAs, desaturase activities and fasting plasma lipids in youth with T1D mixed effects models were used for each individual PUFAs, D5D and D6D, adjusted for demographics, clinic site, diabetes duration, insulin regimen, insulin dose/kg, HbA1c, insulin sensitivity score, and body mass index with random effects to account for the repeated measurements. FINDINGS: Favorable lipid associations were found between LA and low-density lipoprotein (LDL) cholesterol (β=-0.58, p<0.05); AA, plasma triglycerides (TG) (β=-0.04, p<0.05) and TG/high-density lipoprotein (HDL)-C ratio (β=-0.04, p<0.05); and D5D, plasma TG (β=-0.2, p<0.05) and TG/HDL-cholesterol ratio (β=-0.23, p<0.05). Findings were mixed for the n-3 PUFAs and DGLA: ALA was positively associated with plasma TG (β=0.33, p<0.05) and HDL cholesterol (β=9.86, p<0.05); EPA was positively associated with total cholesterol (β=8.17, p<0.05), LDL cholesterol (β=5.74, p<0.01) and HDL cholesterol (β=2.27, p<0.01); and DGLA was positively associated with TG/HDL-cholesterol ratio (β=0.05, P<0.05). CONCLUSION: Findings suggest that the most abundant PUFA, LA as well as its metabolic bi-product AA, may be important targets for CVD lipid risk factor reduction in youth with T1D.
Authors: D Dabelea; R B D'Agostino; C C Mason; N West; R F Hamman; E J Mayer-Davis; D Maahs; G Klingensmith; W C Knowler; K Nadeau Journal: Diabetologia Date: 2010-10-01 Impact factor: 10.122
Authors: L M Steffen; B Vessby; D R Jacobs; J Steinberger; A Moran; C-P Hong; A R Sinaiko Journal: Int J Obes (Lond) Date: 2008-06-17 Impact factor: 5.095
Authors: Janet A Tooze; Natalie S The; Jamie L Crandell; Sarah C Couch; Elizabeth J Mayer-Davis; Corinna Koebnick; Angela D Liese Journal: Nutrients Date: 2020-03-28 Impact factor: 5.717
Authors: Amélie I S Sobczak; Samantha J Pitt; Terry K Smith; Ramzi A Ajjan; Alan J Stewart Journal: Biochim Biophys Acta Mol Cell Biol Lipids Date: 2020-10-01 Impact factor: 4.698